← Open Payments lookup

THOMAS NOWOTNY: Open Payments

NPI 1134284904 · ST LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,733 in 178 payments from 21 companies in 2025. Trend: 2023 $1,890 · 2024 $2,802 · 2025 $2,733

Food & beverage: $2,722Education: $11
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.25$433
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$345
ABBVIE INC.27$279
Alkermes, Inc.14$243
Otsuka America Pharmaceutical, Inc.17$242
Supernus Pharmaceuticals, Inc.19$195
Vanda Pharmaceuticals Inc.10$184
Lundbeck LLC8$143
Axsome Therapeutics, Inc.8$143
Janssen Pharmaceuticals, Inc4$93

Products named: COBENFY, CAPLYTA, REXULTI, VRAYLAR, ARISTADA, Qelbree, FANAPT, Auvelity.

Industry payments across MO — which companies pay providers there.